网站主页 >> CAS数据库列表 >> N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺
N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺
|
|
- CAS号:
- 151823-14-2
- 英文名:
- Sapacitabine
- 英文别名:
- CNDAC;CS-682;CYC 682;CS-2513;Sapacitabine;10G, 50G, 100G, 1KG;Sapacitabine (CS682;Sapacitabine (CYC682);CYC 682; CYC-682; CS-682; CS682; CS 682;1-(2-Deoxy-2-cyano-β-D-arabinofuranosyl)cytosine
- 中文名:
- N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺
- 中文别名:
- 沙帕他滨;化合物SAPACITABINE;N-[1-(2-氰基-2-脱氧-Β-D-阿拉伯呋喃糖基)-1,2-二氢-2-氧代-4-嘧啶基]十六烷酰胺;N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺
- CBNumber:
- CB91261450
- 分子式:
- C26H42N4O5
- 分子量:
- 490.64
- MOL File:
- 151823-14-2.mol
|
|
|
N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺化学性质
-
熔点:
-
>177°C (dec.)
-
|
-
密度:
-
1.21±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
-20°C Freezer, Under inert atmosphere
-
|
-
溶解度:
-
DMSO (Slightly), Methanol (Slightly, Heated)
-
|
-
酸度系数(pKa):
-
10.04±0.20(Predicted)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
White to Off-White
-
|
N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺性质、用途与生产工艺
Sapacitabine 是口服可用的核苷类似物前体药物,与阿糖胞苷结构上相关。
Concentrations of Sapacitabine required to achieve an IC
50
range from 3±0.6 μM for the colon cancer cell line HCT116 to 67±14 μM for the breast cancer cell line MDA-MB-435. Cell cycle analysis shows that 35% Sapacitabine-treated cells are arrested in late-S phase and 41% in G
2
/M phase. L1210 cells with deoxycytidine kinase (dCK) activity are sensitive to Sapacitabine, (IC
50
20±6 μM). In the docetaxel/Sapacitabine combinations, synergistic effects (CI<1) are observed when docetaxel is given before Sapacitabine in both cell lines.
On Day 14, the Sapacitabine (5 mg/kg)+vorinostat (33 mg/kg) group has a mean tumour volume of 245 mm
3
and a tumour growth inhibition (TGI) of 92%, whereas the Sapacitabine (15 mg/kg)+vorinostat (33 mg/kg) group has a mean tumour volume of 107 mm
3
and a TGI of 112%.
N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-16445 | N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺 Sapacitabine | 151823-14-2 | 5mg | 750元 |
2024/04/30 | HY-16445 | N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺 Sapacitabine | 151823-14-2 | 10mM * 1mLin DMSO | 810元 |
N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺
生产厂家
151823-14-2, N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺 相关搜索:
- 核苷类
- C26H42N4O5
- 50-27-8
- 化合物SAPACITABINE
- 沙帕他滨
- N-[1-(2-氰基-2-脱氧-Β-D-阿拉伯呋喃糖基)-1,2-二氢-2-氧代-4-嘧啶基]十六烷酰胺
- N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺
- 151823-14-2
- Sapacitabine (CS682
- Hexadecanamide, N-[1-(2-cyano-2-deoxy-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]-
- CYC 682; CYC-682; CS-682; CS682; CS 682
- CS-2513
- CS-682
- 10G, 50G, 100G, 1KG
- Sapacitabine (CYC682)
- CYC 682
- 2'-cyano-2'-deoxy-N4-palMitoyl-1-β-D-arabinofuranosyl-cytosine, sapacitabine, CYC682
- 1-(2-cyano-2-deoxy-β-D-arabinofuranosyl)-4-(palMitoylaMino)pyriMidin-2(1H)-one,Sapacitabine
- CNDAC
- 4-Amino-1-[(3β-cyano-4α-hydroxy-5β-hydroxymethyltetrahydrofuran)-2β-yl]pyrimidin-2(1H)-one
- 1-(2-Deoxy-2-cyano-β-D-arabinofuranosyl)cytosine
- 1-(2-C-Cyano-2-deoxy-β-D-arabino-pentofuranosyl)cytosine
- Sapacitabine
- N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2- oxo-pyrimidin-4-yl]hexadecanamide